EDGAR Filing Documents for 0001493152-23-023012

Form 8-K - Current report:

SEC Accession No. 0001493152-23-023012

Filing Date

2023-06-30

Accepted

2023-06-30 08:59:27

Documents

Period of Report

2023-06-28

Items

Item 1.01: Entry into a Material Definitive Agreement
Item 3.02: Unregistered Sales of Equity Securities
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Interactive Data

Document Format Files

Seq	Description	Document	Type	Size
1		form8-k.htm iXBRL	8-K	55495
2		ex4-1.htm	EX-4.1	111526
3		ex4-2.htm	EX-4.2	118137
4		ex4-3.htm	EX-4.3	118634
5		ex5-1.htm	EX-5.1	12498
6		ex10-1.htm	EX-10.1	282369
7		ex99-1.htm	EX-99.1	15029
	Complete submission text file	0001493152-23-023012.txt		1036999

Data Files

Seq	Description	Document	Type	Size
8	INLINE XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT	sonn-20230628.xsd	EX-101.SCH	3018
9	INLINE XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT	sonn-20230628_lab.xml	EX-101.LAB	34240
10	INLINE XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT	sonn-20230628_pre.xml	EX-101.PRE	22361
12	EXTRACTED XBRL INSTANCE DOCUMENT	form8-k_htm.xml	XML	3328

Mailing Address 100 OVERLOOK CENTER SUITE 102 PRINCETON NJ 08540

Business Address 100 OVERLOOK CENTER SUITE 102 PRINCETON NJ 08540 609-375-2227

Sonnet BioTherapeutics Holdings, Inc. (Filer) CIK: 0001106838 (see all company filings)